NR2F1 and cancer: The co-expression of NR2F1 (a dormancy marker) and SOX9 (a dormancy and cancer stem cell marker) preferentially in SM tumor cells suggests that these cancer cells adopt both dormant and cancer stem cell properties, a unique biology associated with the SM process.